My Year of Living Wonderfully: 12 Months as ASCO President

Each year, the ASCO President chooses a theme for his or her term, which is not a trivial pursuit. Trying to think up something novel and catchy...

Hepatobiliary Cancer

Adjuvant Capecitabine for Biliary Tract Cancer Yields Significant Improvement in Overall Survival

There is no standard adjuvant therapy for patients with resectable biliary tract cancer, but that may be about to change based on results...

ASCO CEO Reflects on His First Year in Office and What Is Ahead

June 27, 2017, marks the 1-year anniversary since Clifford A. Hudis, MD, FACP, FASCO, began his tenure as Chief Executive Officer of ASCO...


Advertisement

More Top Stories

Kidney Cancer

Toni K. Choueiri, MD, on Untreated RCC: Phase II Trial Results

Pancreatic Cancer

Hydroxychloroquine Boosts Antitumor Activity of Neoadjuvant Chemotherapy for Pancreatic Cancer

Adding hydroxychloroquine, an inhibitor of autophagy, to neoadjuvant chemotherapy for pancreatic cancer increases its efficacy and alters the tumor’s molecular profile in a way that may render the tumor more susceptible to immune checkpoint inhibitors, according to interim data from a phase II...

Advertisement

Non–V600 BRAF Mutations in Metastatic Colorectal Cancer

As reported by Jones et al in the Journal of Clinical Oncology, BRAF mutations occurring outside of codon 600 are found in a small proportion of cases of metastatic colorectal cancer and are associated with improved clinical outcome. Study Details The retrospective cohort study involved 9,643...

Prostate Cancer

Charles G. Drake, MD, PhD, on Prostate Cancer and Immunology: Expert Perspective

Rafal Dziadziuszko, MD, PhD, Receives 2017 Heine H. Hansen Award

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) awarded the 2017 Heine H. Hansen Award to Rafal Dziadziuszko, MD, PhD, at the European Lung Cancer Conference (ELCC) 2017, which was held May 5–8 in Geneva, Switzerland. The...

Supportive Care
Breast Cancer

Anticipate Sexual Dysfunction in Patients on Aromatase Inhibitors

For patients with breast cancer starting on aromatase inhibitors, sexual dysfunction is commonly reported. Early intervention may lessen its impact—but it’s not an easy fix, says a specialist in this area, Leslie R. Schover, PhD. Dr. Schover is Founder of Will2Love, an online sexual health...

Tai Chi Chih vs Cognitive Behavioral Therapy for Insomnia in Breast Cancer Survivors

In a study reported in the Journal of Clinical Oncology by Irwin et al, Tai Chi Chih, a form of movement meditation, was noninferior to insomnia-specific cognitive behavioral therapy in improving insomnia in breast cancer survivors. Study Details In the study, 90 patients with insomnia from the...

Breast Cancer
Prostate Cancer
Issues in Oncology

Diana D. Jeffery, PhD, on Mental Health Comorbidities: Predictors of Cost and Utilization

Breast Cancer
Genomics/Genetics

Suboptimal Genetic Testing and Counseling Among Women With Newly Diagnosed Breast Cancer

In a population-based study reported in a research letter in JAMA, Allison W. Kurian, MD, of Stanford University School of Medicine, and colleagues found that genetic testing and genetic counseling are suboptimal among women with newly diagnosed breast cancer.1 Study Details The study involved...

Advertisement

ASCO and Other Oncology, Medical Societies Speak Out Against White House’s Proposed Budget Cuts

On May 23, President Trump presented the White House’s fiscal year 2018 budget request, which proposes a $7.18 billion cut to the National Institutes of Health (NIH)—a budget decrease of 21%. In addition, it cuts the Center for Disease Control and Prevention’s chronic disease...


click me